• No results found

[PDF] Top 20 Formulation and evaluation of Losartan Potassium matrix tablets for oral controlled release

Has 10000 "Formulation and evaluation of Losartan Potassium matrix tablets for oral controlled release" found on our website. Below are the top 20 most common "Formulation and evaluation of Losartan Potassium matrix tablets for oral controlled release".

Formulation and evaluation of Losartan Potassium matrix tablets
for oral controlled release

Formulation and evaluation of Losartan Potassium matrix tablets for oral controlled release

... various matrix tablets is indicated in table 2. The formulated matrix tablets released the drug for 24 hours and follow near zero order release (formulations: F1, F4, F5 to F7, F9 to ... See full document

6

Formulation and In-Vitro Evaluation of Gabapentin Oral Controlled Release Matrix Tablets

Formulation and In-Vitro Evaluation of Gabapentin Oral Controlled Release Matrix Tablets

... of controlled release drug delivery systems, coupled with the increasing expense in bringing new drug entities to market, has encouraged the development of new drug delivery ... See full document

112

Development and evaluation of liquid oral controlled release systems for Losartan potassium

Development and evaluation of liquid oral controlled release systems for Losartan potassium

... the formulation is another important factor that can determine the rate of the drug release from in situ gelling ...liquid formulation into cellulose bags and incubation in ... See full document

8

DESIGN AND EVALUATION OF LOSARTAN POTASSIUM MATRIX TABLETS WITH NATURAL AND SYNTHETIC POLYMERS

DESIGN AND EVALUATION OF LOSARTAN POTASSIUM MATRIX TABLETS WITH NATURAL AND SYNTHETIC POLYMERS

... the matrix. The major drawback of using natural drugs alone in the matrix tablet formulations is, they could not retard the drug release more than 6-10 hrs 2 ...of matrix tablets in the ... See full document

6

Formulation and Evaluation of Bilayer Tablets of Losartan Potassium for Immediate Release and Metformin Hydrochloride for Sustained Release

Formulation and Evaluation of Bilayer Tablets of Losartan Potassium for Immediate Release and Metformin Hydrochloride for Sustained Release

... bilayer controlled release matrix tablets of Losartan ...tablet. Losartan potassium was formulated as immediate release as well as sustained release ... See full document

141

FORMULATION AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FINASTERIDE

FORMULATION AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FINASTERIDE

... develop oral controlled release matrix tablet formulations of Finasteride using Eudragit and Hydroxypropyl methylcellulose (HPMC) as a hydrophilic release retardant polymer and to study ... See full document

8

Formulation and Evaluation of Losartan Potassium Osmotic Controlled Matrix Tablets

Formulation and Evaluation of Losartan Potassium Osmotic Controlled Matrix Tablets

... Osmotically controlled oral drug delivery systems utilize osmotic pressure as energy source for the controlled delivery of drugs, independent of pH and hydrodynamic conditions of gastro intestinal ... See full document

9

Formulation and In Vitro Evaluation of Floating Tablets of Losartan Potassium.

Formulation and In Vitro Evaluation of Floating Tablets of Losartan Potassium.

... Hydro dynamically balanced systems (HBS) are designed to prolong the stay of the dosage form in the gastro intestinal tract and aid in enhancing the absorption. Such systems are best suited for drugs having a better ... See full document

112

MOUTH DISSOLVING TABLETS OF LOSARTAN POTASSIUM: FORMULATION AND EVALUATION

MOUTH DISSOLVING TABLETS OF LOSARTAN POTASSIUM: FORMULATION AND EVALUATION

... Losartan potassium is an angiotention receptor antagonist, used in the management of ...dissolving/disintegrating tablets (MDTs) of losartan Potassium, which avoid the first-pass ... See full document

10

Formulation and Evaluation of Losartan Potassium and Hydrochlorthiazide Conventional Tablets.

Formulation and Evaluation of Losartan Potassium and Hydrochlorthiazide Conventional Tablets.

... instant release film coating formulations, based on HPMC, PVA and a PEG-PVA graft ...or formulation, a process time reduction of more than 30 percent is achievable, a result that serves the purpose of both, ... See full document

118

FORMULATION AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF SIMVASTATIN

FORMULATION AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF SIMVASTATIN

... a controlled release matrix tablet of simvastatin a drug which is used in the treatment of ...a controlled release formulation of simvastatin is ...developed. Controlled ... See full document

16

Formulation and in vitro evaluation of controlled release matrix tablets of nicotinic acid using xyloglucon and other hydrphilic polymers

Formulation and in vitro evaluation of controlled release matrix tablets of nicotinic acid using xyloglucon and other hydrphilic polymers

... In vitro release studies were carried out using tablets dissolution test Apparatus 11(Basket Method). The dissolution medium consisted of 0.1 N hydrochloric acid (pH 1.2) for first 2 hrs and phosphate ... See full document

6

FORMULATION AND EVALUATION OF CARBAMAZEPINE SUSTAINED RELEASE ORAL MATRIX TABLETS

FORMULATION AND EVALUATION OF CARBAMAZEPINE SUSTAINED RELEASE ORAL MATRIX TABLETS

... drug release from the tablet ...drug release form the tablets not much more ...drug release was due to erosion and it mainly depends on the Eudragit RSPO but not on HPMC ... See full document

9

FORMULATION DESIGN AND EVALUATION OF CEPHALEXIN CONTROLLED RELEASE MATRIX TABLETS

FORMULATION DESIGN AND EVALUATION OF CEPHALEXIN CONTROLLED RELEASE MATRIX TABLETS

... Twenty tablets of each type of formulation are weighed and crushed in mortar and powder equivalent to 100 mg of cephalexin is weighed and dissolved in 100 ml of ... See full document

12

FORMULATION AND IN VITRO EVALUATION OF LOSARTAN POTASSIUM MUCOADHESIVE BUCCAL TABLETS

FORMULATION AND IN VITRO EVALUATION OF LOSARTAN POTASSIUM MUCOADHESIVE BUCCAL TABLETS

... The Losartan release rate from buccal tablets was studied using the USP type II (paddle) dissolution test ...apparatus. Tablets were supposed to release the drug from one side only; ... See full document

6

Fabrication and Characterization of Taste Masked Porous Tablets of Losartan Potassium by Sublimation Technique

Fabrication and Characterization of Taste Masked Porous Tablets of Losartan Potassium by Sublimation Technique

... technologies, evaluation tests. They described about the oral absorption test and different dissolution medias used in the evaluation of the ...best formulation that they reported after the ... See full document

153

Development and evaluation of controlled porosity osmotic pump tablet of losartan potassium

Development and evaluation of controlled porosity osmotic pump tablet of losartan potassium

... the oral osmotically driven system ...reliable controlled drug delivery systems (CDDS) and can be employed as oral drug delivery ...to release the drug in a controlled ... See full document

11

Formulation Development and In-Vitro Evaluation of
Potassium Chloride Extended Release Tablets

Formulation Development and In-Vitro Evaluation of Potassium Chloride Extended Release Tablets

... drug release from the dosage ...of oral solid dosage form, including tablets, capsules, multiparticulates and drug ...of tablets in a coating pan, the tablet surfaces become covered with a ... See full document

90

Formulation and Evaluation of Hydroxypropyl Methylcellulose-based Controlled Release Matrix Tablets for Theophylline

Formulation and Evaluation of Hydroxypropyl Methylcellulose-based Controlled Release Matrix Tablets for Theophylline

... Theophylline is a bronchodilator that relieves airflow obstruction in chronic asthma and decreases its symptoms. Theophylline is well absorbed by the gastrointestinal tract, and several sustained-release ... See full document

6

Formulation and Evaluation of Immediate Release Bilayer Tablets of Amlodipine Besylate and Losartan Potassium

Formulation and Evaluation of Immediate Release Bilayer Tablets of Amlodipine Besylate and Losartan Potassium

... in controlled delivery of drugs to the oral ...drug release. The bilaminated films shows a sustained drug release in a phosphate buffer (pH ... See full document

152

Show all 10000 documents...